1 / 19

Benjamin J. Miller, MD, MS on behalf of the Musculoskeletal Oncology Research Initiative

Advanced Imaging is overused Prior to Referral to a Musculoskeletal Oncologist: A Prospective, Multi-Center Investigation . Benjamin J. Miller, MD, MS on behalf of the Musculoskeletal Oncology Research Initiative. Conflicts of Interest. Nothing to disclose. Background.

kamil
Download Presentation

Benjamin J. Miller, MD, MS on behalf of the Musculoskeletal Oncology Research Initiative

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Advanced Imaging is overused Prior to Referral to a Musculoskeletal Oncologist: A Prospective, Multi-Center Investigation Benjamin J. Miller, MD, MS on behalf of the Musculoskeletal Oncology Research Initiative

  2. Conflicts of Interest • Nothing to disclose

  3. Background • Bone and soft tissue tumors initially seen by general orthopaedist or PCP • No clear guidelines for use of advanced imaging (MRI, CT, bone scan, U/S, PET) • Medical imaging identified as contributor to overspending • Reducing superfluous imaging studies prior to referral is important

  4. Prior studies • Aboulafiaet al, CORR, 2002 • Prospective, single center, 100 patients • 34% unnecessary MRI scans • Martin et al, CORR, 2012 • Retrospective, single-center, 920 patients • 3% unnecessary MRI

  5. Questions • Is there regional variation in the use of advanced imaging? • Are there common characteristics predictive of excessive studies?

  6. Materials and Methods • 8 centers • Prospective • 50 patients or 6 months of referrals • Bone and soft tissue tumors • All anatomic locations

  7. Data elements • Patient details • Age, sex, race, insurance • Tumor type • Bone or soft tissue • Specialty of referring MD • Distance travelled • Studies performed prior to referral

  8. Subjective material • Determined only by the single treating orthopaedic oncologist • What happens in actual practice? • Presumptive diagnosis • Likely benign (Benign tumor or non-neoplastic) • Likely malignant (Malignant tumor or unknown) • Necessary or excessive study

  9. “Necessary study” criteria • Needed for routine work-up of condition • Helpful in determining diagnosis • Borderline studies considered “necessary” • Benefit of the doubt given to referring physician

  10. “Necessary study” criteria • MRI specifically • Soft tissue • Biopsy proven sarcoma • >5 cm • Deep to fascia • Painful • Growing • Bone • Concern for sarcoma on x-ray

  11. Statistical analysis • Chi-square and t test • Univariate and multivariate logistic regression • Post hoc power analysis • 90% power to detect 20% difference between centers

  12. Results • 371 patients • 301 (81%) with at least 1 study • 263 (71%) with MRI • 54 (15%) with CT • 40 (11%) with bone scan • 21 (6%) with ultrasound • 14 (4%) with PET scan • 81 (22%) with multiple studies

  13. Results • Regions differed by age, race, insurance status, and distance travelled • Demographics variable • No differences in use of prereferral imaging by region (p=0.164) • Range 66% to 88%

  14. Results • 113 (30%) with unnecessary studies • 46 (17%) MRI • 40 (74%) CT • 25 (62%) bone scan • 16 (76%) ultrasound • 7 (50%) PET scan • No difference between orthopaedic or PCP referrals (p=0.940)

  15. Univariate analysis • Benign bone tumors more likely to have excessive imaging (OR 2.18, 95% CI 1.39-3.43) • Differences by practice location • Findings held in multivariate analysis

  16. Effect of Region • No obvious differences in number or types of studies • Generalizable results • Differences in labeling “unnecessary” • Substantial variation between fellowship-trained tumor surgeons • Consistent with prior studies • Minimum 3% (Martin 3%) and maximum 31% (Aboulafia 34%) • Need for clearer guidelines based on objective, reproducible criteria

  17. Summary • Helpful – MRI • Most utilized study (71%) • 83% deemed necessary • Use contrast, visualize entire compartment • 6% repeated • Not helpful – everything else • High rate of “unnecessary” • Should be left to treating team

  18. Recommendations • Appropriate advanced imaging is beneficial • Goal is not to totally eliminate • No imaging other than MRI • No MRI in radiographically benign bone tumors • Would change 30% excessive studies to 4%

  19. MORI participants • RaffiAvedian • Judd Cummings • Tessa Balach • Kevin MacDonald • Lee Leddy • Jeremy White • Raj Rajani • Ben Miller

More Related